Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Critical Care
Published in: Critical Care 3/2008

01-06-2008 | Letter

Antifungal prophylaxis in critically ill patients

Authors: Luciano Silvestri, Durk F Zandstra, Hendrick KF van Saene, Andy J Petros, Sujatha Thyagarajan, Miguel A de la Cal, Corrado Thomann

Published in: Critical Care | Issue 3/2008

Login to get access

Excerpt

We congratulate van Till and colleagues on their review showing that selective decontamination of the digestive tract (SDD) is more effective than single-drug prophylaxis (SAP) in reducing yeast colonisation, infection and mortality [1]. …
Literature
1.
van Till JWO, van Ruler O, Lamme B, Weber RJP, Reitsma JB, Boermeester MA: Single-drug therapy or selective decontamination of the digestive tract as antifungal prophylaxis in critically ill patients: a systematic review. Crit Care 2007, 11: R126. 10.1186/cc6191PubMedCentralCrossRefPubMed
2.
Silvestri L, van Saene HKF, Milanese M, Gregori D: Impact of selective decontamination of the digestive tract on fungal carriage and infection. Systematic review of randomized controlled trials. Intensive Care Med 2005, 31: 898-910. 10.1007/s00134-005-2654-9CrossRefPubMed
3.
van Saene HKF, Silvestri L, Petros A, Viviani M, de la Cal MA, Zandstra DF: Comment on 'Prevention of severe Candida infections in non-neutropenic, high-risk, critically ill patients' by Garbino et al. Intensive Care Med 2003, 29: 1192-1193. 10.1007/s00134-003-1770-7CrossRefPubMed
Metadata
Title
Antifungal prophylaxis in critically ill patients
Authors
Luciano Silvestri
Durk F Zandstra
Hendrick KF van Saene
Andy J Petros
Sujatha Thyagarajan
Miguel A de la Cal
Corrado Thomann
Publication date
01-06-2008
Publisher
BioMed Central
Published in
Critical Care / Issue 3/2008
Electronic ISSN: 1364-8535
DOI
https://doi.org/10.1186/cc6906

Other articles of this Issue 3/2008

Critical Care 3/2008 Go to the issue

Research

The role of corticosteroids in severe community-acquired pneumonia: a systematic review

Research

Oral probiotic and prevention of Pseudomonas aeruginosa infections: a randomized, double-blind, placebo-controlled pilot study in intensive care unit patients

Commentary

Probiotics in the intensive care unit: why controversies and confusion abound

Commentary

How best to recruit the injured lung?

Commentary

Recently published papers: a little less ventilation, a little more oxygen please?

Research

Antimicrobial treatment for ventilator-associated tracheobronchitis: a randomized, controlled, multicenter study